Literature DB >> 21222121

Roles and mechanisms of microRNAs in pancreatic cancer.

Lidong Zhang1, Md Saha Jamaluddin, Sarah M Weakley, Qizhi Yao, Changyi Chen.   

Abstract

Pancreatic cancer (PC) is an aggressive malignancy with poor survival. The discovery of microRNAs (miRNAs) has provided a new opportunity to study the disease. Thus far, altered expression of miRNAs has been reported in a wide range of malignancies, including PC, and some miRNAs are associated with PC cell proliferation, invasion, chemoresistance, and patient survival. This review summarizes recent advances with respect to the roles and mechanisms of miRNAs in PC and discusses potential clinical applications.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21222121      PMCID： PMC3275100          DOI： 10.1007/s00268-010-0952-z

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


  69 in total

1.  Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.

Authors:  Richard I Gregory; Thimmaiah P Chendrimada; Neil Cooch; Ramin Shiekhattar
Journal:  Cell       Date:  2005-11-03       Impact factor: 41.582

2.  MicroRNA expression profiles in serous ovarian carcinoma.

Authors:  Eun Ji Nam; Heejei Yoon; Sang Wun Kim; Hoguen Kim; Young Tae Kim; Jae Hoon Kim; Jae Wook Kim; Sunghoon Kim
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

3.  The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.

Authors:  Naïma Hanoun; Yannick Delpu; Arief A Suriawinata; Barbara Bournet; Christophe Bureau; Janick Selves; Gregory J Tsongalis; Marlène Dufresne; Louis Buscail; Pierre Cordelier; Jérôme Torrisani
Journal:  Clin Chem       Date:  2010-04-29       Impact factor: 8.327

4.  Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.

Authors:  Shadan Ali; Aamir Ahmad; Sanjeev Banerjee; Subhash Padhye; Kristin Dominiak; Jacqueline M Schaffert; Zhiwei Wang; Philip A Philip; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

5.  MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival.

Authors:  Kaitlyn Wurz; Rochelle L Garcia; Barbara A Goff; Patrick S Mitchell; Jun Haeng Lee; Muneesh Tewari; Elizabeth M Swisher
Journal:  Genes Chromosomes Cancer       Date:  2010-07       Impact factor: 5.006

6.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.

Authors:  Mark Bloomston; Wendy L Frankel; Fabio Petrocca; Stefano Volinia; Hansjuerg Alder; John P Hagan; Chang-Gong Liu; Darshna Bhatt; Cristian Taccioli; Carlo M Croce
Journal:  JAMA       Date:  2007-05-02       Impact factor: 56.272

7.  A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.

Authors:  Ankur K Nagaraja; Chad J Creighton; Zhifeng Yu; Huifeng Zhu; Preethi H Gunaratne; Jeffrey G Reid; Emuejevoke Olokpa; Hiroaki Itamochi; Naoto T Ueno; Shannon M Hawkins; Matthew L Anderson; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2010-01-15

8.  Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development.

Authors:  Meritxell Gironella; Mylène Seux; Min-Jue Xie; Carla Cano; Richard Tomasini; Julien Gommeaux; Stephane Garcia; Jonathan Nowak; Man Lung Yeung; Kuan-Teh Jeang; Amandine Chaix; Ladan Fazli; Yoshiharu Motoo; Qing Wang; Palma Rocchi; Antonio Russo; Martin Gleave; Jean-Charles Dagorn; Juan L Iovanna; Alice Carrier; Marie-Josèphe Pébusque; Nelson J Dusetti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

9.  MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells.

Authors:  Hongping Xia; Yanting Qi; Samuel S Ng; Xiaona Chen; Shen Chen; Marong Fang; Dan Li; Yu Zhao; Ruiguang Ge; Guo Li; Yangchao Chen; Ming-Liang He; Hsiang-fu Kung; Lihui Lai; Marie C Lin
Journal:  Biochem Biophys Res Commun       Date:  2009-01-09       Impact factor: 3.575

Review 10.  MicroRNAs: control and loss of control in human physiology and disease.

Authors:  Min Li; Christian Marin-Muller; Uddalak Bharadwaj; Kwong-Hon Chow; Qizhi Yao; Changyi Chen
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352
View more
  19 in total

1.  Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.

Authors:  Neveen Abd El Moneim Hussein; Zenat A El Kholy; Medhat M Anwar; Mohamed A Ahmad; Shaymaa M Ahmad
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-15       Impact factor: 4.553

Review 2.  MicroRNAs in pancreatic malignancy: progress and promises.

Authors:  Sanjeev K Srivastava; Sumit Arora; Seema Singh; Arun Bhardwaj; Courey Averett; Ajay P Singh
Journal:  Cancer Lett       Date:  2014-02-20       Impact factor: 8.679

Review 3.  Contribution of bioinformatics prediction in microRNA-based cancer therapeutics.

Authors:  Jasjit K Banwait; Dhundy R Bastola
Journal:  Adv Drug Deliv Rev       Date:  2014-11-06       Impact factor: 15.470

Review 4.  miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma.

Authors:  Anteneh A Tesfaye; Asfar S Azmi; Philip A Philip
Journal:  Am J Pathol       Date:  2019-01       Impact factor: 4.307

Review 5.  Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.

Authors:  Satyanarayana Rachagani; Muzafar A Macha; Nicholas Heimann; Parthasarathy Seshacharyulu; Dhanya Haridas; Seema Chugh; Surinder K Batra
Journal:  Adv Drug Deliv Rev       Date:  2014-10-23       Impact factor: 15.470

6.  Microfluidic device for high-throughput affinity-based isolation of extracellular vesicles.

Authors:  Ting-Wen Lo; Ziwen Zhu; Emma Purcell; Daniel Watza; Joyful Wang; Yoon-Tae Kang; Shruti Jolly; Deepak Nagrath; Sunitha Nagrath
Journal:  Lab Chip       Date:  2020-05-19       Impact factor: 6.799

7.  Mast cells, disease and gastrointestinal cancer: A comprehensive review of recent findings.

Authors:  Kyle Hodges; Lindsey Kennedy; Fanyin Meng; Gianfranco Alpini; Heather Francis
Journal:  Transl Gastrointest Cancer       Date:  2012-02-08

8.  MicroRNA-204 attenuates the migration and invasion of pancreatic cancer cells by targeting ZEB1/EMT axis.

Authors:  Huihan Zhang; Mingqiao Li; Xiaodong Xu
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

9.  Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma.

Authors:  Zi-Man Zhu; Yue-Fang Xu; Qin-Jun Su; Jun-Dong Du; Xiang-Long Tan; Yu-Liang Tu; Jing-Wang Tan; Hua-Bao Jiao
Journal:  Mol Cell Biochem       Date:  2013-11-17       Impact factor: 3.396

10.  Manganese superoxide dismutase expression is negatively associated with microRNA-301a in human pancreatic ductal adenocarcinoma.

Authors:  H Pandit; W Zhang; Y Li; S Agle; X Li; S P Li; G Cui; Y Li; R C G Martin
Journal:  Cancer Gene Ther       Date:  2015-09-18       Impact factor: 5.987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.